Bionano Genomics Inc (BNGO) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $1.73 (-0.57%), Market cap $0.01B, 52-week low–high $1.09 ~ $4.92.
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr and Stratys instruments, which are single-molec
Financial statements, price targets, institutional (13F) holdings and related news for Bionano Genomics Inc are updated in real time on BlackAll Trade.
Bionano Genomics Inc trades at $1.73 (-0.57%). Real-time quotes and charts are available on BlackAll Trade.
Bionano Genomics Inc has a market cap of about $0.01B.
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia.